Browse by Journal Title

Article

Modeling chemotherapy induced neurotoxicity with human induced pluripotent stem cell (iPSC)-derived sensory neurons.
Schinke, C. and Vallone, V.F. and Ivanov, A. and Peng, Y. and Körtvelyessy, P. and Nolte, L. and Huehnchen, P. and Beule, D. and Stachelscheid, H. and Boehmerle, W. and Endres, M.
Neurobiology of Disease 155 : 105391. July 2021

Neurofibromatosis 1 - mutant microglia exhibit sexually-dimorphic cyclic AMP-dependent purinergic defects.
Elmadany, N. and Logiacco, F. and Buonfiglioli, A. and Haage, V. and Wright-Jin, E.C. and Schattenberg, A. and Papawassiliou, R. and Kettenmann, H. and Semtner, M. and Gutmann, D.H.
Neurobiology of Disease 144 : 105030. October 2020

Loss of DJ-1 impairs antioxidant response by altered glutamine and serine metabolism.
Meiser, J. and Delcambre, S. and Wegner, A. and Jaeger, C. and Ghelfi, J. and D'Herouel, A.F. and Dong, X. and Weindl, D. and Stautner, C. and Nonnenmacher, Y. and Michelucci, A. and Popp, O. and Giesert, F. and Schildknecht, S. and Kraemer, L. and Schneider, J.G. and Woitalla, D. and Wurst, W. and Skupin, A. and Weisenhorn, D.M.V. and Krueger, R. and Leist, M. and Hiller, K.
Neurobiology of Disease 89 : 112-125. May 2016

L1 syndrome mutations impair neuronal L1 function at different levels by divergent mechanisms.
Schaefer, M.K.E. and Nam, Y.C. and Moumen, A. and Keglowich, L. and Bouche, E. and Kueffner, M. and Bock, H.H. and Rathjen, F.G. and Raoul, C. and Frotscher, M.
Neurobiology of Disease 40 (1): 222-237. October 2010

Increased inhibitory input to CA1 pyramidal cells alters hippocampal gamma frequency oscillations in the MK-801 model of acute psychosis.
Kehrer, C. and Dugladze, T. and Maziashvili, N. and Wojtowicz, A. and Schmitz, D. and Heinemann, U. and Gloveli, T.
Neurobiology of Disease 25 (3): 545-552. March 2007

Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage.
Prigione, A. and Begni, B. and Galbussera, A. and Beretta, S. and Brighina, L. and Garofalo, R. and Andreoni, S. and Piolti, R. and Ferrarese, C.
Neurobiology of Disease 23 (1): 36-43. July 2006

Proliferative response of distinct hippocampal progenitor cell populations after cortical infarcts in the adult brain.
Kunze, A. and Grass, S. and Witte, O.W. and Yamaguchi, M. and Kempermann, G. and Redecker, C.
Neurobiology of Disease 21 (2): 324-332. February 2006

Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease.
Hockly, E. and Tse, J. and Barker, A.L. and Moolman, D.L. and Beunard, J.L. and Revington, A.P. and Holt, K. and Sunshine, S. and Moffitt, H. and Sathasivam, K. and Woodman, B. and Wanker, E.E. and Lowden, P.A. and Bates, G.P.
Neurobiology of Disease 21 (1): 228-236. January 2006

Estrogen suppresses the impact of glucose deprivation on astrocytic calcium levels and signaling independently of the nuclear estrogen receptor.
Arnold, S.
Neurobiology of Disease 20 (1): 82-92. October 2005

The CHRNB2 mutation I312M is associated with epilepsy and distinct memory deficits.
Bertrand, D. and Elmslie, F. and Hughes, E. and Trounce, J. and Sander, T. and Bertrand, S. and Steinlein, O.K.
Neurobiology of Disease 20 (3): 799-804. 17 June 2005

Review

Epigenetics of cell fate reprogramming and its implications for neurological disorders modelling.
Grzybek, M. and Golonko, A. and Walczak, M. and Lisowski, P.
Neurobiology of Disease 99 : 84-120. March 2017